30 Jun 2025
// PR NEWSWIRE
27 May 2025
// FIERCE PHARMA
01 May 2025
// PR NEWSWIRE
About
Industry Trade Show
Not Confirmed
26-28 August, 2025
ChemOutsourcingChemOutsourcing
Industry Trade Show
Attending
08-10 September, 2025
Industry Trade Show
Attending
15-16 September, 2025
CONTACT DETAILS
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
26-28 August, 2025
ChemOutsourcingChemOutsourcing
Industry Trade Show
Attending
08-10 September, 2025
Industry Trade Show
Attending
15-16 September, 2025
30 Jun 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/us-food-and-drug-administration-accepts-for-review-allergan-aesthetics-premarket-approval-application-for-skinvive-by-juvederm-for-the-improvement-of-neck-appearance-302494011.html
27 May 2025
// FIERCE PHARMA
https://www.fiercepharma.com/pharma/abbvies-allergan-aesthetics-business-tightens-202-layoffs-california
01 May 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/botox-cosmetic-onabotulinumtoxina-continues-its-mission-of-empowering-entrepreneurs-through-the-confidence-project-302444121.html
24 Mar 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/allergan-aesthetics-emphasizes-commitment-to-innovation-science-and-a-patient-centric-approach-at-amwc-2025-302409039.html
12 Feb 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/allergan-aesthetics-to-launch-three-new-state-of-the-art-training-centers-in-the-us-expanding-access-to-high-quality-aesthetics-training-302374118.html
05 Feb 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/allergan-aesthetics-the-american-society-of-plastic-surgeons-asps-and-the-aesthetic-society-release-two-new-engaging-limitless-videos-celebrating-women-surgeons-302368870.html
RLD : Yes
TE Code : AB
Dosage Form : TABLET; SUBLINGUAL
Proprietary Name : SAPHRIS
Dosage Strength : EQ 5MG BASE
Approval Date : 2009-08-13
Application Number : 22117
RX/OTC/DISCN : RX
RLD : Yes
TE Code : AB
RLD : Yes
TE Code : AB
Dosage Form : TABLET; SUBLINGUAL
Proprietary Name : SAPHRIS
Dosage Strength : EQ 10MG BASE
Approval Date : 2009-08-13
Application Number : 22117
RX/OTC/DISCN : RX
RLD : Yes
TE Code : AB
RLD : Yes
TE Code : AB
Dosage Form : TABLET; SUBLINGUAL
Proprietary Name : SAPHRIS
Dosage Strength : EQ 2.5MG BASE
Approval Date : 2015-03-12
Application Number : 22117
RX/OTC/DISCN : RX
RLD : Yes
TE Code : AB
RLD : Yes
TE Code :
Dosage Form : TABLET; ORAL
Proprietary Name : FIORINAL
Dosage Strength : 325MG;50MG;40MG **Federa...
Approval Date : 1986-04-16
Application Number : 17534
RX/OTC/DISCN : DISCN
RLD : Yes
TE Code :
RLD : Yes
TE Code :
Dosage Form : CAPSULE; ORAL
Proprietary Name : FIORINAL
Dosage Strength : 325MG;50MG;40MG **Federa...
Approval Date : 1986-04-16
Application Number : 17534
RX/OTC/DISCN : DISCN
RLD : Yes
TE Code :
RLD : Yes
TE Code :
ASPIRIN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE
Dosage Form : CAPSULE; ORAL
Proprietary Name : FIORINAL W/CODEINE
Dosage Strength : 325MG;50MG;40MG;30MG
Approval Date : 1990-10-26
Application Number : 19429
RX/OTC/DISCN : DISCN
RLD : Yes
TE Code :
RLD : No
TE Code :
Dosage Form : SOLUTION/DROPS; OPHTHALMIC
Proprietary Name : ALPHAGAN
Dosage Strength : 0.5%
Approval Date : 1997-03-13
Application Number : 20490
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
RLD : Yes
TE Code :
Dosage Form : SOLUTION/DROPS; OPHTHALMIC
Proprietary Name : ALPHAGAN
Dosage Strength : 0.2% **Federal Register ...
Approval Date : 1996-09-06
Application Number : 20613
RX/OTC/DISCN : DISCN
RLD : Yes
TE Code :
RLD : No
TE Code :
Dosage Form : SOLUTION/DROPS; OPHTHALMIC
Proprietary Name : CHLOROPTIC
Dosage Strength : 0.5%
Approval Date : 1982-01-01
Application Number : 50091
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
RLD : No
TE Code :
Dosage Form : OINTMENT; OPHTHALMIC
Proprietary Name : CHLOROPTIC S.O.P.
Dosage Strength : 1%
Approval Date : 1982-01-01
Application Number : 61187
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
Inspections and registrations
ABOUT THIS PAGE
Allergan Plc is a supplier offers 1 products (APIs, Excipients or Intermediates).
Find a price of Botulinum toxin type A bulk offered by Allergan Plc